Medical Affairs team kicks off international islet cell therapy workshops at Breakthrough T1D HQ
Breakthrough T1D's Medical Affairs team hosted experts in islet transplantation to discuss a clinical roadmap for manufactured cell therapies.
New Breakthrough T1D publications highlight unmet needs and demographics of the T1D population
Breakthrough T1D recently published two peer-reviewed journal articles. One detailed burdensome unmet needs in the T1D community and identified key…
Riding coast to coast for cures
Matt Varey, a key volunteer with Breakthrough T1D, will embark on a two-month-long, 7,500 km cycling journey across Canada to…
From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant…
ATTD 2025: Closing the loop to cures
At ATTD 2025, Breakthrough T1D led sessions showcasing advancements in T1D cell therapies, early detection, and technology to improve lives.
From Breakthrough T1D trainee to Principal Investigator: Kelsey Voss, Ph.D., is calling the shots
Kelsey Voss, Ph.D., received Breakthrough T1D's Advanced Postdoctoral Fellowship Award, which helped start her lab at UVA studying T cells…
Shining the spotlight on Breakthrough T1D scientist Dr. Cassandra Bazile
Dr. Cassandra Bazile is a scientist at Breakthrough T1D who champions community, mentorship, and inclusion in STEM.
The extraordinary contributions of African Americans to healthcare
Join Breakthrough T1D in honoring African American pioneers who have made significant contributions to research, science, and healthcare.
Breakthrough T1D Mourns Tragic, Sudden Loss of Five Ride Champions
The leadership, staff, and volunteers of Breakthrough T1D mourn the recent loss of five Ride champions.
A bittersweet goodbye for Sydney Yovic, Breakthrough T1D Chief Strategy Officer and Chief of Staff
A look back at her career here, and a look forward at her future as CEO of our Australia affiliate.
